|
BIIB033 (also known as Anti-LINGO-1) is a monoclonal antibody targeting LINGO1. It is currently being developed by Biogen as a treatment for diseases such as multiple sclerosis and optic neuritis. == See also == * Ocrelizumab 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「BIIB033」の詳細全文を読む スポンサード リンク
|